Wellfort Co., Ltd. Welcomes Masahiro Okabe as New Board Member

Wellfort Co., Ltd., a leading provider of health monitoring services, has recently appointed Masahiro Okabe as a board member, effective August 2025. Based in Minato, Tokyo, Wellfort is renowned for its innovative health solutions, including the cutting-edge service known as Welltect (Wellfort Website). Okabe brings an impressive portfolio of experience from his roles in various startups as well as major companies such as E-Entry, a former joint venture between Accenture and SoftBank, where he served as CEO.

Background of Masahiro Okabe

Okabe’s extensive corporate career includes several notable positions:

- Former President at Andersen Consulting (now Accenture)
- Current President of E-Entry Inc.
- Former CEO of SystemSoft Corporation (TSE: 7527)
- Founder and former director at Gigi Co., Ltd. (Kodomo Gochimeshi)
- Current President of Orb Inc. (Blockchain)
- Former Executive Officer at Trust Bank, Inc.
- Former Director at Qulamedia

Notably, Okabe is also a cancer survivor, having been diagnosed with stage 4 cancer in 2023. Faced with the prospect of significant quality of life reductions after recommended surgery, he pursued alternative treatments, eventually achieving a complete response through advanced chemotherapy, radiation, and fasting techniques without surgery. Presently, Okabe is cancer-free, confirmed through ctDNA testing which detects no cancer at the genetic level.

As a “pro patient,” Okabe has dedicated himself to studying and implementing effective strategies for disease prevention, focusing on exercise, nutrition, sleep, supplements, and mental health. He also researches trustworthy medical professionals, hospitals, and treatment options in the event of a recurrence, emphasizing early detection and awareness. He aims to leverage his unique experiences and insights to enhance Wellfort’s mission of supporting health management for its clients.

Comments from Key Figures

Daisaku Honda, the Chairman of Wellfort, expressed enthusiasm for Okabe’s appointment: "We are thrilled to welcome Masahiro Okabe as a new board member. His profound insights gained from his personal battle with illness, combined with his extensive management experience, make him a rare asset for our company. I am confident that his perspective and strong conviction will enhance our health-related services and contribute to the promotion of health and happiness for many individuals. Together, we will expand our health monitoring services for corporate executives, safeguarding human resources and stabilizing corporate management through health prevention. Furthermore, we will strive to raise awareness about the importance of health habits, enabling more people to lead fulfilling lives."

Introducing Welltect

Welltect is a comprehensive health monitoring service that integrates at-home genetic testing, blood work, cancer risk assessments, online health consultations with physicians, and AI-based disease prediction diagnostics. Through its genetic testing, Welltect evaluates risks for over 500 hereditary diseases and evaluates health conditions related to lifestyle diseases via blood tests. For those exceeding certain thresholds in cancer risk assessments, the service covers an annual cancer health check (including CT and PET scans) at a total cost of 200,000 yen. Based on test results, online health consultations with physicians and AI diagnostics utilizing a database of 4.6 million health check records are available, ensuring optimal support for health management.

For more information, visit Wellfort’s website.